MoneyWorks4Me

Indoco Remedies - Quaterly Results

24 Jul 2025 Evaluate
The revenue slipped marginally during the June 2025 quarter. A decline of about Rs. 3925.30 millions was observed as compared to Rs. 4014.30 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2025 is Rs. -280.60 millions as compared to Net Profit of Rs. 149.50 millions of corresponding quarter ended June 2024Operating profit for the quarter ended June 2025 decreased to 204.10 millions as compared to 550.90 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 3925.30 4014.30 -2.22 3925.30 4014.30 -2.22 15181.90 17908.10 -15.22
Other Income 55.80 35.20 58.52 55.80 35.20 58.52 184.80 85.10 117.16
PBIDT 204.10 550.90 -62.95 204.10 550.90 -62.95 1465.20 2664.90 -45.02
Interest 236.10 118.80 98.74 236.10 118.80 98.74 566.30 368.20 53.80
PBDT -32.00 432.10 -107.41 -32.00 432.10 -107.41 908.80 2412.00 -62.32
Depreciation 252.00 237.00 6.33 252.00 237.00 6.33 982.50 879.80 11.67
PBT -284.00 195.10 -245.57 -284.00 195.10 -245.57 -73.70 1532.20 -104.81
TAX -3.40 45.60 -107.46 -3.40 45.60 -107.46 13.60 365.80 -96.28
Deferred Tax -3.40 -1.70 100.00 -3.40 -1.70 100.00 13.60 38.10 -64.30
PAT -280.60 149.50 -287.69 -280.60 149.50 -287.69 -87.30 1166.40 -107.48
Equity 184.50 184.40 0.05 184.50 184.40 0.05 184.50 184.40 0.05
PBIDTM(%) 5.20 13.72 -62.11 5.20 13.72 -62.11 9.65 14.88 -35.15
Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..